Adams-Oliver syndrome: Additions to the clinical features and possible role of BMP pathway

American Journal of Medical Genetics, Part A

Volumn 149, Issue 8, 2009, Pages 1678-1684

  Baskar, Shankar ^a   Kulkarni, Muralidhar Laxmanrao ^a   Kulkarni, Akhil Muralidhar ^a   Vittalrao, Suhasini ^a   Kulkarni, Preethi Muralidhar ^a  

^a J J M MEDICAL COLLEGE   (India)

Author keywords

Adams Oliver syndrome; Bone age measurements; Bone morphogenetic proteins; Cutis aplasia; Finger phalanges; Limb reduction defect; Metacarpophalangeal pattern profile

Indexed keywords

ANTIBIOTIC AGENT; BONE MORPHOGENETIC PROTEIN; CLONIDINE; FOLLITROPIN; GROWTH HORMONE; LUTEINIZING HORMONE;

ADAMS OLIVER SYNDROME; ARTICLE; BIRTH WEIGHT; BLEEDING; BONE DEVELOPMENT; CASE REPORT; CHILD; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEVELOPMENTAL DISORDER; DISTAL PHALANX; ECHOGRAPHY; FEMALE; FOLLITROPIN BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; HAIR GROWTH; HAND MALFORMATION; HOSPITAL DEPARTMENT; HUMAN; LIMB DEFECT; LUTEINIZING HORMONE BLOOD LEVEL; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PHENOTYPE; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIMARY HEALTH CARE; PRIORITY JOURNAL; SKIN ULCER; STANFORD-BINET INTELLIGENCE SCALE; TERM BIRTH; WOUND DRESSING;

ABNORMALITIES, MULTIPLE; BONE MORPHOGENETIC PROTEINS; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LIMB DEFORMITIES, CONGENITAL; PHENOTYPE; SCALP; SIGNAL TRANSDUCTION; SYNDROME; TOMOGRAPHY, X-RAY COMPUTED;

EID: 68049105183     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.32938     Document Type: Article

References (50)

1. Abzhanov A, Rodda SJ, McMahon AP, Tabin CJ. 2007. Regulation of skeletogenic differentiation in cranial dermal bone. Development 134: 3133-3144. (Pubitemid 47506152)
2. Adams FH, Oliver CP. 1945. Hereditary deformities in man due to arrested development. J Hered 36:3-7.
3. Biesecker LG, Aase JM, Clericuzio C, Gurrieri F, Temple IK, Toriello H. 2009. Elements of morphology: Standard terminology for the hands and feet. Am J Med Genet Part A 149A:93-127.
4. Bonafede RP, Beighton P. 1979. Autosomal dominant inheritance of scalp defects with ectrodactyly. Am J Med Genet 3:35-41.
5. Borg K, Pfeifle J. 1992. Multifocal aplasia cutis congenita, distal limb hemimelia, and cutis marmorata telangiectatica in a patient with Adams Oliver syndrome. Br J Dermatol 127:160-163.
6. Costa T, Ramsby G, Cassia F, Peters KR, Soares J, Correa J, Quelce-Salgado A, Tsipouras P. 1998. Grebe syndrome: Clinical and radiographic findings in affected individuals and heterozygous carriers. Am J Med Genet 75:523-529. (Pubitemid 28078526)
7. David L, Mallet C, Keramidas M, Lamandé N, Gasc JM, Dupuis Girod S, Plauchu H, Feige JJ, Bailly S. 2008. Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circ Res 102:914-922. (Pubitemid 351591550)
8. Davies RJ, Morrell NW. 2008. Molecular mechanisms of pulmonary arterial hypertension: Role of mutations in the bone morphogenetic protein type II receptor. Chest 134:1271-1277.
9. Der Kaloustian VM, Hoyme ME, Hogg H, Entin MA, Guttmacher AE. 1991. Possible common pathogenetic mechanisms for Poland sequence and Adams-Oliver syndrome. Am J Med Genet 38:69-73.
10. Digilio MC, Marino B, Dallapiccola B. 2008. Autosomal dominant inheritance of aplasia cutis congenita and congenital heart defect: A possible link to the Adams-Oliver syndrome. Am J Med Genet Part A 146A: 2842-2844.
11. Farrell SA, Warda LJ, LaFlair P, Szymonowicz W. 1993. Adams-Oliver syndrome: A case with juvenile chronic myelogenous leukemia and chylothorax. Am J Med Genet 47:1175-1179. (Pubitemid 23340178)
12. Fryns JP, Van den Berghe H. 1979. Congenital scalp defects associated with postaxial polydactyly. Hum Genet 49:217-219. (Pubitemid 9250701)
13. Fryns JP, Legius E, Demaerel P, van den Berghe H. 1996. Congenital scalp defect, distal limb reduction anomalies, right spastic hemiplegia and hypoplasia of the left arteria cerebri media. Further evidence that interruption of early embryonic blood supply may result in Adams- Oliver (plus) syndrome. Clin Genet 50:505-509.
14. Garn SM, Hertzog KP, Poznanski AK, Nagy JM. 1972. Metacarpophalangeal length in the evaluation of skeletal malformation. Radiology 105:375-381.
15. Girard M, Amiel J, Fabre M, Pariente D, Lyonnet S, Jacquemin E. 2005. Adams-Oliver syndrome and hepatoportal sclerosis: Occasional association or common mechanism? Am J Med Genet 135:186-189.
16. Govoni KE, Lee SK, Chadwick RB,YuH, Kasukawa Y, Baylink DJ,MohanS. 2006. Whole genome microarray analysis of growth hormone-induced gene expression in bone: T-box3, a novel transcription factor, regulates osteoblast proliferation. Am J Physiol Endocrinol Metab 291:E128-E136. (Pubitemid 44035317)
17. Greulich WW, Pyle SI. 1959. Radiographic atlas of skeletal development of the hand and wrist. Stanford, CA: Stanford University Press.
18. Guo X, Wang XF. 2009. Signalling cross-talk between TGF-beta/BMP and other pathways. Cell Res 19:71-88.
19. HoganBL. 1996. Bone morphogenetic proteins: Multifunctional regulators of vertebrate development. Genes Dev 10:1580-1594.
20. Hoyme HE, Jones KL, Van Allen MI, Saunders BS, Benirschke K. 1982. Vascular pathogenesis of transverse limb reduction defects. J Pediatr 101: 839-843.
21. Kaartinen V, Dudas M, Nagy A, Sridurongrit S, Lu MM, Epstein JA. 2004. Cardiac outflow tract defects in mice lacking ALK2 in neural crest cells. Development 131:3481-3490. (Pubitemid 39139893)
22. Kamat V. 1967. Measuring intelligence of Indian children. 4th edition. London: Oxford University Press.
23. Keymolen K, De Smet L, Bracke P, Fryns JP. 1999. The concurrence of ring constrictions in Adams-Oliver syndrome: Additional evidence for vascular disruption as common pathogenetic mechanism. Genet Couns 10: 295-300. (Pubitemid 29473771)
24. Lehmann K, Seemann P, Stricker S, Sammar M, Meyer B, Süring K, Majewski F, Tinschert S, Grzeschik KH, Müller D, Knaus P, Nürnberg P, Mundlos S. 2003. Mutations in bone morphogenetic protein receptor 1B cause brachydactyly type A2. Proc Natl Acad Sci USA 100: 12277-12282. (Pubitemid 37271551)
25. Lehmann K, Seemann P, Boergermann J, Morin G, Reif S, Knaus P, Mundlos S. 2006. A novel R486Q mutation in BMPR1B resulting in either a brachydactyly type C/symphalangism-like phenotype or brachydactyly type A2. Eur J Hum Genet 14:1248-1254. (Pubitemid 44804030)
26. Lehmann K, Seemann P, Silan F, Goecke TO, Irgang S, Kjaer KW, Kjaergaard S, Mahoney MJ, Morlot S, Reissner C, Kerr B, Wilkie AO, Mundlos S. 2007. A new subtype of brachydactyly type B caused by point mutations in the bone morphogenetic protein antagonist NOGGIN. Am J Hum Genet 81:388-396. (Pubitemid 47236086)
27. Lin AE, Westgate M-N, van der Velde ME, Lacro RV, Holmes LB. 1998. Adams-Oliver syndrome associated with cardiovascular malformations. Clin Dysmorphol 7:235-241. (Pubitemid 28518754)
28. Liu D, Wang J, Kinzel B, Müeller M, Mao X, Valdez R, Liu Y, Li E. 2007. Dosage dependent requirement ofBMP type II receptor for maintenance of vascular integrity. Blood 110:1502-1510. (Pubitemid 47443965)
29. Mempel M, Abeck D, Lange I, Strom K, Caliebe A, Beham A, Kautza M, Worret WI, Neubauer BA, Ring J, Schröder H, Fölster-Holst R. 1999. The wide spectrum of clinical expression in Adams-Oliver syndrome: A report of two cases. Br J Dermatol 140:1157-1160. (Pubitemid 29284595)
30. Miyazono K, Maeda S, Imamura T. 2005. BMP receptor signalling: Transcriptional targets, regulation of signals, and signalling cross talk. Cytokine Growth Factor Rev 16:251-263. (Pubitemid 40910315)
31. Papadopoulou E, Sifakis S, Raissaki M, Germanakis I, Kalmanti M. 2008. Antenatal and postnatal evidence of periventricular leukomalacia as a further indication of vascular disruption in Adams-Oliver syndrome. Am J Med Genet Part A 146A:2545-2550.
32. Patel MS, Taylor GP, Bharya S, Al-Sanna'a N, Adatia I, Chitayat D, Suzanne Lewis ME, Human DG. 2004. Abnormal pericyte recruitment as a cause for pulmonary hypertension in Adams-Oliver syndrome. Am J Med Genet Part A 129A:294-299.
33. Piazza AJ, Blackston D, Sola A. 2004. A case of Adams-Oliver syndrome with associated brain and pulmonary involvement: Further evidence of vascular pathology? Am J Med Genet Part A 130A:172-175.
34. Poznanski AK, Garn SM, Nagy JM, Gall JC Jr. 1972. Metacarpophalangeal pattern profiles in the evaluation of skeletal malformations. Radiology 104:1-11.
35. Prothero J, Nicholl R, Wilson J, Wakeling E. 2007. Aplasia cutis congenital, terminal limb defects and falciform retinal folds: Confirmation of a distinct syndrome of vascular disruption. Clin Dysmorphol 16:39-41. (Pubitemid 44949805)
36. Reddi AH. 2001. Interplay between bone morphogenetic proteins and cognate binding proteins in bone and cartilage development: Noggin, chordin and DAN. Arthritis Res 3:1-5.
37. Reiter EO, Rosenfeld RG. 2008. Normal and aberrant growth. In: KronenbergHM, MelmedS, Polonsky KS, Larsen PR, editors. William's textbook of endocrinology. 11th edition. Philadelphia, PA: Saunders Elsevier.
38. Seemann P, Schwappacher R, Kjaer KW, Krakow D, Lehmann K, Dawson K, Stricker S, Pohl J, Plöger F, Staub E, Nickel J, Sebald W, Knaus P, Mundlos S. 2005. Activating and deactivating mutations in the receptor interaction site of GDF5 cause symphalangism or brachydactyly type A2. J Clin Invest 115:2373-2381. (Pubitemid 41266199)
39. Swartz EN, Sanatani S, Sandor GG, Schreiber RA. 1999. Vascular abnormalities in Adams-Oliver syndrome: Cause or effect? Am J Med Genet 82: 49-52.
40. Sybert VP. 1985. Aplasia cutis congenita: A report of 12 new families and review of the literature. Pediatr Dermatol 3:1-14. (Pubitemid 16208039)
41. Tekin M, Bodurtha J, Ciftci E, Arsan S. 1999. Further family with possible autosomal recessive inheritance of Adams-Oliver syndrome. Am J Hum Genet 86:90-91. (Pubitemid 29387725)
42. Thomas JT, Kilpatrick MW, Lin K, Erlacher L, Lembessis P, Costa T, Tsipouras P, Luyten FP. 1997. Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1. Nat Genet 17:58-64. (Pubitemid 27377532)
43. Toriello HV, Graff RG, Florentine MF, Lacina S, Moore WD. 1988. Scalp and limb defects with cutis marmorata telangiectatica congenita: Adams- -Oliver syndrome? Am J Med Genet 29:269-276.
44. Trembath RC, Thomson JR, Machado RD, Morgan NV, Atkinson C, Winship I, Simonneau G, Galie N, Loyd JE, Humbert M, Nichols WC, Morrell NW, Berg J, Manes A, McGaughran J, Pauciulo M, Wheeler L. 2001. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 345:367-371. (Pubitemid 32703235)
45. Van Wijk B, Moorman AF, van den Hoff MJ. 2007. Role of bone morphogenetic proteins in cardiac differentiation. Cardiovasc Res 74:244-255. (Pubitemid 46517505)
46. Verdyck P, Holder-Espinasse M, Van Hul W, Wuyts W. 2003. Clinical and molecular analysis of nine families with Adams-Oliver syndrome. Eur J Hum Genet 11:457-463. (Pubitemid 36722265)
47. Verdyck P, Blaumeiser B, Holder-Espinasse M, VanHulW,WuytsW.2006. Adams-Oliver syndrome: Clinical description of a four-generation family and exclusion of five candidate genes. Clin Genet 69:86-92. (Pubitemid 43372228)
48. Whitley CB, Gorlin RJ. 1991. Adams-Oliver syndrome revisited. Am J Med Genet 40:319-326.
49. Wilson WG, Harcus SJ. 1982. Variable expression of a congenital scalp defects/limb malformations syndrome in three generations. In: Nyhan WL, Jones KL, editors. Dysmorphology. New York: Alan R. Liss, Inc. for the March of Dimes. Birth Defects Foundation BD:OAS XVIII (3B). pp. 123-128.
50. Zehnaly A, Hosokawa R, Urata M, Chai Y. 2007. TGF-beta signaling and aplasia cutis congenita: Proposed animal model. J Calif Dent Assoc Dec 35:865-869.